ID   THEM4_HUMAN             Reviewed;         240 AA.
AC   Q5T1C6; B2RBX2; Q96KR2;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   07-APR-2021, entry version 140.
DE   RecName: Full=Acyl-coenzyme A thioesterase THEM4;
DE            Short=Acyl-CoA thioesterase THEM4;
DE            EC=3.1.2.2 {ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024};
DE   AltName: Full=Carboxyl-terminal modulator protein;
DE   AltName: Full=Thioesterase superfamily member 4;
DE   Flags: Precursor;
GN   Name=THEM4; Synonyms=CTMP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH AKT1, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND VARIANT ARG-17.
RX   PubMed=11598301; DOI=10.1126/science.1062030;
RA   Maira S.-M., Galetic I., Brazil D.P., Kaech S., Ingley E., Thelen M.,
RA   Hemmings B.A.;
RT   "Carboxyl-terminal modulator protein (CTMP), a negative regulator of
RT   PKB/Akt and v-Akt at the plasma membrane.";
RL   Science 294:374-380(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-17.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-17.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-17.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15026474; DOI=10.1093/jnci/djh064;
RA   Knobbe C.B., Reifenberger J., Blaschke B., Reifenberger G.;
RT   "Hypermethylation and transcriptional downregulation of the carboxyl-
RT   terminal modulator protein gene in glioblastomas.";
RL   J. Natl. Cancer Inst. 96:483-486(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=17615157; DOI=10.1152/ajpcell.00570.2006;
RA   Ono H., Sakoda H., Fujishiro M., Anai M., Kushiyama A., Fukushima Y.,
RA   Katagiri H., Ogihara T., Oka Y., Kamata H., Horike N., Uchijima Y.,
RA   Kurihara H., Asano T.;
RT   "Carboxy-terminal modulator protein induces Akt phosphorylation and
RT   activation, thereby enhancing antiapoptotic, glycogen synthetic, and
RT   glucose uptake pathways.";
RL   Am. J. Physiol. 293:C1576-C1585(2007).
RN   [8]
RP   PHOSPHORYLATION AT SER-37 AND SER-38, IDENTIFICATION BY MASS SPECTROMETRY,
RP   MUTAGENESIS OF 37-SER-SER-38, AND SUBCELLULAR LOCATION.
RX   PubMed=19604401; DOI=10.1186/1471-2121-10-53;
RA   Piao L., Li Y., Yang K.J., Park K.A., Byun H.S., Won M., Hong J., Kim J.L.,
RA   Kweon G.R., Hur G.M., Seok J.H., Cho J.Y., Chun T., Hess D., Sack R.,
RA   Maira S.M., Brazil D.P., Hemmings B.A., Park J.;
RT   "Heat shock protein 70-mediated sensitization of cells to apoptosis by
RT   carboxyl-terminal modulator protein.";
RL   BMC Cell Biol. 10:53-53(2009).
RN   [9]
RP   CATALYTIC ACTIVITY, FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19453107; DOI=10.1021/bi900710w;
RA   Zhao H., Martin B.M., Bisoffi M., Dunaway-Mariano D.;
RT   "The Akt C-terminal modulator protein is an acyl-CoA thioesterase of the
RT   Hotdog-Fold family.";
RL   Biochemistry 48:5507-5509(2009).
RN   [10]
RP   SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS OF SER-37.
RX   PubMed=19168129; DOI=10.1016/j.cellsig.2009.01.016;
RA   Parcellier A., Tintignac L.A., Zhuravleva E., Cron P., Schenk S.,
RA   Bozulic L., Hemmings B.A.;
RT   "Carboxy-terminal modulator protein (CTMP) is a mitochondrial protein that
RT   sensitizes cells to apoptosis.";
RL   Cell. Signal. 21:639-650(2009).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19421406; DOI=10.1371/journal.pone.0005471;
RA   Parcellier A., Tintignac L.A., Zhuravleva E., Dummler B., Brazil D.P.,
RA   Hynx D., Cron P., Schenk S., Olivieri V., Hemmings B.A.;
RT   "The carboxy-terminal modulator protein (CTMP) regulates mitochondrial
RT   dynamics.";
RL   PLoS ONE 4:E5471-E5471(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 40-240 IN COMPLEX WITH
RP   UNDECAN-2-ONE-COA, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, FUNCTION, ACTIVE SITE, INTERACTION WITH AKT1, AND MUTAGENESIS OF
RP   HIS-152; ASP-161; THR-177; ASN-183; ARG-206 AND LYS-207.
RX   PubMed=22871024; DOI=10.1021/bi300968n;
RA   Zhao H., Lim K., Choudry A., Latham J.A., Pathak M.C., Dominguez D.,
RA   Luo L., Herzberg O., Dunaway-Mariano D.;
RT   "Correlation of structure and function in the human hotdog-fold enzyme
RT   hTHEM4.";
RL   Biochemistry 51:6490-6492(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.59 ANGSTROMS) OF 37-240, AND SUBUNIT.
RX   PubMed=22586271; DOI=10.1128/mcb.00312-12;
RA   Zhuravleva E., Gut H., Hynx D., Marcellin D., Bleck C.K., Genoud C.,
RA   Cron P., Keusch J.J., Dummler B., Esposti M.D., Hemmings B.A.;
RT   "Acyl coenzyme A thioesterase Them5/Acot15 is involved in cardiolipin
RT   remodeling and fatty liver development.";
RL   Mol. Cell. Biol. 32:2685-2697(2012).
RN   [14]
RP   VARIANTS ARG-17 AND CYS-38.
RX   PubMed=17013611; DOI=10.1007/s00401-006-0128-y;
RA   Schick V., Majores M., Engels G., Spitoni S., Koch A., Elger C.E.,
RA   Simon M., Knobbe C., Bluemcke I., Becker A.J.;
RT   "Activation of Akt independent of PTEN and CTMP tumor-suppressor gene
RT   mutations in epilepsy-associated Taylor-type focal cortical dysplasias.";
RL   Acta Neuropathol. 112:715-725(2006).
CC   -!- FUNCTION: Has acyl-CoA thioesterase activity towards medium and long-
CC       chain (C14 to C18) fatty acyl-CoA substrates, and probably plays a role
CC       in mitochondrial fatty acid metabolism. Plays a role in the apoptotic
CC       process, possibly via its regulation of AKT1 activity. According to
CC       PubMed:11598301, inhibits AKT1 phosphorylation and activity. According
CC       to PubMed:17615157, enhances AKT1 activity by favoring its
CC       phosphorylation and translocation to plasma membrane.
CC       {ECO:0000269|PubMed:11598301, ECO:0000269|PubMed:17615157,
CC       ECO:0000269|PubMed:19168129, ECO:0000269|PubMed:19421406,
CC       ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hexadecanoyl-CoA = CoA + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:16645, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379; EC=3.1.2.2;
CC         Evidence={ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16646;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + octanoyl-CoA = CoA + H(+) + octanoate;
CC         Xref=Rhea:RHEA:30143, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:25646, ChEBI:CHEBI:57287, ChEBI:CHEBI:57386;
CC         Evidence={ECO:0000269|PubMed:19453107};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30144;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=decanoyl-CoA + H2O = CoA + decanoate + H(+);
CC         Xref=Rhea:RHEA:40059, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:27689, ChEBI:CHEBI:57287, ChEBI:CHEBI:61430;
CC         Evidence={ECO:0000269|PubMed:19453107};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40060;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + H2O = CoA + dodecanoate + H(+);
CC         Xref=Rhea:RHEA:30135, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57287, ChEBI:CHEBI:57375;
CC         Evidence={ECO:0000269|PubMed:19453107};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30136;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + tetradecanoyl-CoA = CoA + H(+) + tetradecanoate;
CC         Xref=Rhea:RHEA:40119, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57287, ChEBI:CHEBI:57385;
CC         Evidence={ECO:0000269|PubMed:19453107};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40120;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + H2O = (9Z)-octadecenoate + CoA + H(+);
CC         Xref=Rhea:RHEA:40139, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387;
CC         Evidence={ECO:0000269|PubMed:19453107};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40140;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + H2O = (5Z,8Z,11Z,14Z)-
CC         eicosatetraenoate + CoA + H(+); Xref=Rhea:RHEA:40151,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368;
CC         Evidence={ECO:0000269|PubMed:19453107};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40152;
CC         Evidence={ECO:0000305|PubMed:19453107};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.4 uM for myristoyl-CoA {ECO:0000269|PubMed:19453107,
CC         ECO:0000269|PubMed:22871024};
CC         KM=2.6 uM for palmitoyl-CoA {ECO:0000269|PubMed:19453107,
CC         ECO:0000269|PubMed:22871024};
CC         KM=5.2 uM for oleoyl-CoA {ECO:0000269|PubMed:19453107,
CC         ECO:0000269|PubMed:22871024};
CC   -!- SUBUNIT: Homodimer and homotetramer. Interacts with AKT1 in the
CC       cytosol. {ECO:0000269|PubMed:11598301, ECO:0000269|PubMed:22586271,
CC       ECO:0000269|PubMed:22871024}.
CC   -!- INTERACTION:
CC       Q5T1C6; P31749: AKT1; NbExp=4; IntAct=EBI-7684443, EBI-296087;
CC       Q5T1C6; P22607: FGFR3; NbExp=3; IntAct=EBI-7684443, EBI-348399;
CC       Q5T1C6; P01112: HRAS; NbExp=3; IntAct=EBI-7684443, EBI-350145;
CC       Q5T1C6; P16284: PECAM1; NbExp=3; IntAct=EBI-7684443, EBI-716404;
CC       Q5T1C6; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-7684443, EBI-5235340;
CC       Q5T1C6; P08670: VIM; NbExp=3; IntAct=EBI-7684443, EBI-353844;
CC       Q5T1C6; Q9Y649; NbExp=3; IntAct=EBI-7684443, EBI-25900580;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11598301}. Cell
CC       projection, ruffle membrane {ECO:0000269|PubMed:11598301}. Cytoplasm
CC       {ECO:0000269|PubMed:19604401}. Mitochondrion
CC       {ECO:0000269|PubMed:19168129, ECO:0000269|PubMed:19421406,
CC       ECO:0000269|PubMed:19604401}. Mitochondrion inner membrane; Peripheral
CC       membrane protein {ECO:0000269|PubMed:19168129}. Mitochondrion
CC       intermembrane space {ECO:0000269|PubMed:19168129,
CC       ECO:0000269|PubMed:19604401}. Note=Released from the mitochondria into
CC       the cytosol in response to apoptotic stimuli.
CC       {ECO:0000269|PubMed:19168129}.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in skeletal muscle, testis,
CC       uterus, brain and kidney. Down-regulated in glioblastoma or glioma
CC       compared to non-neoplastic brain due to promoter hypermethylation.
CC       {ECO:0000269|PubMed:11598301, ECO:0000269|PubMed:15026474}.
CC   -!- PTM: Phosphorylated. {ECO:0000269|PubMed:11598301,
CC       ECO:0000269|PubMed:19604401}.
CC   -!- SIMILARITY: Belongs to the THEM4/THEM5 thioesterase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ313515; CAC86384.1; -; mRNA.
DR   EMBL; AK314852; BAG37369.1; -; mRNA.
DR   EMBL; AL450992; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53400.1; -; Genomic_DNA.
DR   EMBL; BC065277; AAH65277.1; -; mRNA.
DR   CCDS; CCDS1006.1; -.
DR   RefSeq; NP_444283.2; NM_053055.4.
DR   PDB; 4AE8; X-ray; 1.59 A; A/B/C/D=37-240.
DR   PDB; 4GAH; X-ray; 2.30 A; A/B=40-240.
DR   PDBsum; 4AE8; -.
DR   PDBsum; 4GAH; -.
DR   SMR; Q5T1C6; -.
DR   BioGRID; 125557; 73.
DR   DIP; DIP-60764N; -.
DR   IntAct; Q5T1C6; 26.
DR   MINT; Q5T1C6; -.
DR   STRING; 9606.ENSP00000357804; -.
DR   SwissLipids; SLP:000000657; -.
DR   iPTMnet; Q5T1C6; -.
DR   PhosphoSitePlus; Q5T1C6; -.
DR   BioMuta; THEM4; -.
DR   DMDM; 74744451; -.
DR   EPD; Q5T1C6; -.
DR   jPOST; Q5T1C6; -.
DR   MassIVE; Q5T1C6; -.
DR   MaxQB; Q5T1C6; -.
DR   PaxDb; Q5T1C6; -.
DR   PeptideAtlas; Q5T1C6; -.
DR   PRIDE; Q5T1C6; -.
DR   ProteomicsDB; 64259; -.
DR   Antibodypedia; 34077; 82 antibodies.
DR   Ensembl; ENST00000368814; ENSP00000357804; ENSG00000159445.
DR   GeneID; 117145; -.
DR   KEGG; hsa:117145; -.
DR   UCSC; uc001ezj.3; human.
DR   CTD; 117145; -.
DR   DisGeNET; 117145; -.
DR   GeneCards; THEM4; -.
DR   HGNC; HGNC:17947; THEM4.
DR   HPA; ENSG00000159445; Low tissue specificity.
DR   MIM; 606388; gene.
DR   neXtProt; NX_Q5T1C6; -.
DR   OpenTargets; ENSG00000159445; -.
DR   PharmGKB; PA142670813; -.
DR   VEuPathDB; HostDB:ENSG00000159445.12; -.
DR   eggNOG; KOG4781; Eukaryota.
DR   GeneTree; ENSGT00940000160047; -.
DR   HOGENOM; CLU_072603_0_1_1; -.
DR   InParanoid; Q5T1C6; -.
DR   OMA; CIFQAGH; -.
DR   OrthoDB; 1322443at2759; -.
DR   PhylomeDB; Q5T1C6; -.
DR   TreeFam; TF332518; -.
DR   PathwayCommons; Q5T1C6; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-165158; Activation of AKT2.
DR   Reactome; R-HSA-199418; Negative regulation of the PI3K/AKT network.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-77289; Mitochondrial Fatty Acid Beta-Oxidation.
DR   SABIO-RK; Q5T1C6; -.
DR   SIGNOR; Q5T1C6; -.
DR   BioGRID-ORCS; 117145; 11 hits in 992 CRISPR screens.
DR   ChiTaRS; THEM4; human.
DR   GenomeRNAi; 117145; -.
DR   Pharos; Q5T1C6; Tbio.
DR   PRO; PR:Q5T1C6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5T1C6; protein.
DR   Bgee; ENSG00000159445; Expressed in amniotic fluid and 215 other tissues.
DR   ExpressionAtlas; Q5T1C6; baseline and differential.
DR   Genevisible; Q5T1C6; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0102991; F:myristoyl-CoA hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; TAS:Reactome.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0043491; P:protein kinase B signaling; IMP:UniProtKB.
DR   GO; GO:1902108; P:regulation of mitochondrial membrane permeability involved in apoptotic process; IMP:UniProtKB.
DR   InterPro; IPR029069; HotDog_dom_sf.
DR   InterPro; IPR006683; Thioestr_dom.
DR   Pfam; PF03061; 4HBT; 1.
DR   SUPFAM; SSF54637; SSF54637; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; Cell membrane; Cell projection;
KW   Cytoplasm; Fatty acid metabolism; Hydrolase; Lipid metabolism; Membrane;
KW   Mitochondrion; Mitochondrion inner membrane; Phosphoprotein;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..36
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           37..240
FT                   /note="Acyl-coenzyme A thioesterase THEM4"
FT                   /id="PRO_0000314179"
FT   REGION          206..207
FT                   /note="Substrate binding"
FT   ACT_SITE        161
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000305|PubMed:22871024"
FT   BINDING         183
FT                   /note="Substrate"
FT   BINDING         185
FT                   /note="Substrate"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19604401"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19604401"
FT   MOD_RES         55
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UUI3"
FT   MOD_RES         66
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UUI3"
FT   MOD_RES         74
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UUI3"
FT   MOD_RES         98
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UUI3"
FT   MOD_RES         207
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UUI3"
FT   VARIANT         17
FT                   /note="L -> R (in dbSNP:rs3748805)"
FT                   /evidence="ECO:0000269|PubMed:11598301,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17013611, ECO:0000269|Ref.4"
FT                   /id="VAR_037865"
FT   VARIANT         38
FT                   /note="S -> C (in dbSNP:rs144257719)"
FT                   /evidence="ECO:0000269|PubMed:17013611"
FT                   /id="VAR_037866"
FT   MUTAGEN         37..38
FT                   /note="SS->DD: Abolishes import into the mitochondria."
FT                   /evidence="ECO:0000269|PubMed:19604401"
FT   MUTAGEN         37
FT                   /note="S->A: Abolishes cleavage of mitochondrial transit
FT                   peptide."
FT                   /evidence="ECO:0000269|PubMed:19168129"
FT   MUTAGEN         152
FT                   /note="H->A,F: Strongly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22871024"
FT   MUTAGEN         161
FT                   /note="D->E,N: Nearly abolishes enzyme activity. Strongly
FT                   reduced affinity for myristoyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:22871024"
FT   MUTAGEN         177
FT                   /note="T->A: Strongly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22871024"
FT   MUTAGEN         183
FT                   /note="N->A: No effect on enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22871024"
FT   MUTAGEN         206
FT                   /note="R->A: Reduces enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22871024"
FT   MUTAGEN         207
FT                   /note="K->A: Slightly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:22871024"
FT   HELIX           55..67
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   TURN            68..70
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          71..76
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   HELIX           84..93
FT                   /evidence="ECO:0007744|PDB:4GAH"
FT   HELIX           111..113
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   TURN            117..119
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          120..128
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   TURN            129..132
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          133..140
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   HELIX           142..144
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          145..147
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   HELIX           153..172
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          175..184
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          193..204
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          207..216
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   STRAND          222..232
FT                   /evidence="ECO:0007744|PDB:4AE8"
FT   TURN            235..237
FT                   /evidence="ECO:0007744|PDB:4GAH"
SQ   SEQUENCE   240 AA;  27130 MW;  A01071B07A1B5FB2 CRC64;
     MLRSCAARLR TLGALCLPPV GRRLPGSEPR PELRSFSSEE VILKDCSVPN PSWNKDLRLL
     FDQFMKKCED GSWKRLPSYK RTPTEWIQDF KTHFLDPKLM KEEQMSQAQL FTRSFDDGLG
     FEYVMFYNDI EKRMVCLFQG GPYLEGPPGF IHGGAIATMI DATVGMCAMM AGGIVMTANL
     NINYKRPIPL CSVVMINSQL DKVEGRKFFV SCNVQSVDEK TLYSEATSLF IKLNPAKSLT
//
